<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2018.89082</article-id><article-id pub-id-type="publisher-id">OJOG-86477</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Maternal and Fetal Outcomes Following Labour at Term in Singleton Pregnancies with Meconium-Stained Amniotic Fluid: A Prospective Cohort Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Julius</surname><given-names>Sama Dohbit</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Evelyne</surname><given-names>M. Mah</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Felix</surname><given-names>Essiben</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Edmond</surname><given-names>Mesumbe Nzene</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Esther</surname><given-names>U. N. Meka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pascal</surname><given-names>Foumane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Joel</surname><given-names>Noutakdie Tochie</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Benjamin</surname><given-names>Momo Kadia</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Felix</surname><given-names>A. Elong</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Philip</surname><given-names>Njotang Nana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Gynaeco-Obstetric and Pediatric Hospital, Yaounde, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Obstetrics and Gynecology, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon</addr-line></aff><aff id="aff6"><addr-line>Faculty of Health Sciences, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff5"><addr-line>Foumbot District Hospital, Foumbot, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Department of Surgery and Anesthesiology, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Central Hospital of Yaounde, Yaounde, Cameroon</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>joeltochie@gmail.com(JNT)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>07</month><year>2018</year></pub-date><volume>08</volume><issue>09</issue><fpage>790</fpage><lpage>802</lpage><history><date date-type="received"><day>26,</day>	<month>June</month>	<year>2018</year></date><date date-type="rev-recd"><day>3,</day>	<month>August</month>	<year>2018</year>	</date><date date-type="accepted"><day>6,</day>	<month>August</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: 
  Meconium stained amniotic fluid (MSAF) is frequently encountered in obstetric practice. Literature on the subject is still poorly documented in the African setting. <b>Objective</b>
  <b>:</b>
  <b> </b>
  The aim of this study was to determine the maternal and fetal outcomes in case of meconium stained amniotic fluid observed during term labour. <b>Materials and Methods: </b>We conducted a prospective cohort study enrolling all consenting pregnant women with term singleton fetus in cephalic presentation admitted for labour with ruptured fetal membranes in the maternity units of the Yaound&#233; Central Hospital (YCH) and the Yaound&#233; Gynaeco-Obstetric and Pediatric Hospital (YGOPH) of Cameroon between December 2014 and April 2015. The exposed grouped was considered as participants having MSAF, while the non-exposed group comprised those with clear amniotic fluid (CAF). The two groups were monitored during labor using the WHO partograph, and then followed up till 72
   
  hours after delivery. Variables studied included the colour and texture of amniotic fluid as well as maternal and fetal complications. Data was analyzed using Epi-info version 3.5.4. The chi-square and Fischer’s exact tests were appropriate
  ly
   used to compare the two groups. A p-value less than 5% was considered statistically significant. <b>Results: </b>2376 vaginal deliveries were recorded during the study period among which MSAF was observed in 265 cases, hence a prevalence rate of MSAF of 11.15%. Among these cases of MSAF, 52.1% was thick meconium and 47.9% was light meconium. Maternal morbidity was high in the group with MSAF
  ;
   these included
  :
   Higher proportions of caesarean delivery (RR = 2.35 p &lt; 10<sup>-4</sup>) and prolonged labor (RR = 3 p &lt; 10<sup>-4</sup>). In this same group, the incidences of chorioamnionitis and puerperal sepsis were low (0.94% and 0.70% respectively), although there was a three-fold higher risk that was not statistically significant (RR = 3, P = 0.31). Fetal and neonatal outcomes were poorer in the MSAF group compared to the CAF group. The complications included fetal heart rate abnormalities, low Apgar score at the 5<sup>th</sup> minute, need for neonatal resuscitation, neonatal asphyxia and neonatal infection which were significantly higher in the MSAF group (all p &lt; 0.05). Meconium aspiration syndrome (MAS) was found in 2.34% of MSAF cases. Perinatal mortality was 2.34% and all cases of death occurred in the thick MSAF group. <b>Conclusion: </b>MSAF observed during labour is associated with increased perinatal morbidity and mortality. Its detection during labor should strongly indicate very rigorous intra partum and postpartum monitoring. This will ensure optimal management and reduction in the risks of complications.
 
</p></abstract><kwd-group><kwd>Meconium Stained Amniotic Fluid</kwd><kwd> Labour</kwd><kwd> Maternal and Neonatal Outcomes</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Amniotic fluid is a clear and transparent liquid in which the fetus lives. It is principally made up of water (96.4%), mineral salts and organic substances [<xref ref-type="bibr" rid="scirp.86477-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref2">2</xref>]. Its volume increases from 20 ml at 7 weeks of gestation, to 980 ml at 34 weeks and then drops to 540 ml at 42 weeks. Its reabsorption is mainly by fetal swallowing and absorption through the amniotic membrane [<xref ref-type="bibr" rid="scirp.86477-ref2">2</xref>]. Two main abnormalities of amniotic fluid are volume and colour changes. Colour abnormality could be blood or meconium stained (MSAF) [<xref ref-type="bibr" rid="scirp.86477-ref2">2</xref>]. Meconium is the first stool of the fetus or neonate and its emission occurs between 24 and 48 hours of extra uterine life [<xref ref-type="bibr" rid="scirp.86477-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref5">5</xref>]. Certain pathological conditions can cause its emission before delivery, thus staining the amniotic fluid green. MSAF is a common finding in obstetric and neonatal practice with occurrence varying from 5% to 24.6% of deliveries [<xref ref-type="bibr" rid="scirp.86477-ref6">6</xref>]. Its incidence increases with gestational age, up to 30% at 40 weeks and 50% at 42 weeks [<xref ref-type="bibr" rid="scirp.86477-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref8">8</xref>].</p><p>Although the exact cause of this MSAF is unclear, fetal distress, cord accidents and maternal hypertension have been identified as potential risk factors [<xref ref-type="bibr" rid="scirp.86477-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref10">10</xref>]. Intrauterine emission of meconium has both fetal and neonatal consequences as well as maternal risks [<xref ref-type="bibr" rid="scirp.86477-ref5">5</xref>]. Studies done in India and Pakistan showed higher proportions of caesarean delivery, abnormal fetal heart rhythm, meconium inhalation syndrome (MIS), low Apgar score (&lt; 7) at the fifth minute, neonatal sepsis and death in cases of MSAF [<xref ref-type="bibr" rid="scirp.86477-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref13">13</xref>]. In the USA and United Kingdoms, guidelines have been set for the management of cases with MSAF in order to reduce these complications [<xref ref-type="bibr" rid="scirp.86477-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref16">16</xref>]. These guidelines include continuous surveillance and amnioinfusion in cases of thick MSAF. These have led to a significant reduction in caesarean section rates [<xref ref-type="bibr" rid="scirp.86477-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.86477-ref19">19</xref>]. With an extensive literature search, there is lack of studies assessing maternal and neonatal outcomes in case of MSAF in Cameroon. Therefore, this study aimed at determining the fetal, neonatal and maternal complications associated with MSAF in order to improve its management.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Design and Setting</title><p>This was a prospective cohort study which targeted pregnant women admitted in the labor wards of the maternity units of two university teaching hospitals of Cameroon; the Yaounde Central Hospital (YCH) and the Yaounde Gynaeco-Obstetric and Pediatric Hospital of Yaound&#233; (YGOPH). The study was conducted over a 5 months period from December 2014 to April 2015. Uniform and standard operating protocols for the management of labour were in use in both study settings.</p></sec><sec id="s2_2"><title>2.2. Participants, Sampling and Follow-Up</title><p>We included all consecutive and consenting pregnant women presenting with singleton pregnancies at term, fetuses in cephalic presentation and ruptured fetal membranes and who gave their informed consent. We excluded women with pre-term or post term pregnancies, breech and other mal-presentations, multiple gestations, those admitted for elective caesarean, women with unknown last menstrual period and those with intra-uterine fetal death on admission. Cases of MSAF were considered as exposed while those with clear amniotic fluid (CAF) were considered as non-exposed. Women were matched based on parity. Participants were followed up during labor (using the WHO partograph), and 72 hours following delivery, checking for maternal, fetal and neonatal complications. Using a ratio of unexposed group to exposed group of 1, a 95% confidence interval, minimum risk ratio of 2 for differences to be detected, the formula for difference in proportions [<xref ref-type="bibr" rid="scirp.86477-ref20">20</xref>] was used to calculate a minimum sample size was of 150 participants per group. The variables studied were (see appendix 1); 1) Maternal sociodemographic data: maternal age, marital status, level of education and occupation. 2) Obstetric history: parity, gestational age, number of antenatal care visits, pregnancy pathologies. 3) Details of labour: mode of rupture of membranes (spontaneous or artificial), duration of membrane rupture, colour of amniotic fluid (green, yellow, meconium), consistency of amniotic fluid (light or thick), amniotic fluid odour (fetid or non fetid), fetal heart rhythm, APGAR score at the 1<sup>st</sup> and 5<sup>th</sup> minute. 4) Maternal complications: chorioamnionitis, prolonged labour (&gt;12 hours), instrumental delivery, cesarean section, pueperal infections. 5) Neonatal complications: fetal distress (fetal heart rate below 110 beats per minute or above 160 beats per minute [<xref ref-type="bibr" rid="scirp.86477-ref21">21</xref>] ), neonatal asphyxia (diagnosed based on the diagnosed based on the Modified Sarnat-Sarnat Score [<xref ref-type="bibr" rid="scirp.86477-ref22">22</xref>] and a five-minute Apgar score ≤ 3 associated with neurological signs such as hypotonia, coma or convulsions [<xref ref-type="bibr" rid="scirp.86477-ref23">23</xref>] ), neonatal resuscitation, admission into the neonatal unit and neonatal death.</p></sec><sec id="s2_3"><title>2.3. Data Management and Statistical Analysis</title><p>Data was collected using a pretested questionnaire and analyzed using Epi-info version 3.5.4. The Chi-square and Fischer’s exact tests were used to compare the two groups. A p-value of less than 5% was considered statistically significant.</p><p>Ethical considerations: Ethical clearance was obtained from the Institutional Review Board of the Faculty of Medicine and Biomedical Sciences of the University of Yaounde I, Cameroon.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Characteristics of the Study Population</title><p>A total of 2376 deliveries were registered during the study period. Among these there were 265 cases of MSAF, hence, a prevalence of 11.15% for MSAF. Of the 265 cases of MSAF, 52 cases (19.6%) were excluded because of post term gestation, prematurity, breech presentation and multiple gestations. Two-hundred and thirteen (213) labour cases with CAF were matched to the remaining 213 cases of MSAF. The average age of the pregnant women was 27.72 &#177; 5.34 years with extremes of 15 and 40 years. There was no significant difference in ages between the two study groups (<xref ref-type="table" rid="table1">Table 1</xref>). The majority of the women were spinsters (60.3%) and had at least attended secondary education (93.5%). Out of the 426 cases analysed in this study, 248 babies were male and 178 female, giving a sex ratio of 1.39 with a male preponderance. This ratio was similar in the different subgroups. The mean gestational age at delivery was significantly greater in the MSAF group as compared to the CAF group (39.7 weeks vs 39.2 weeks: P = 0.0001). Gestational ages ranging between 40 to 42 weeks was significantly more common in the MSAF group than the CAF group (41.78% vs 26.76%, p = 0.0011). The mean birth weight was 3277.11 &#177; 493.59 g. The weights were similar in the two groups. Cases of prolonged premature rupture of fetal membranes were significantly higher in the MSAF group (p = 0.0047) (<xref ref-type="table" rid="table2">Table 2</xref>). Out of the 213 cases with MSAF, 111 (52.1%) were thick meconium stained amniotic fluid and 102 (47.9%) were lightly stained. In 23.5% of the cases, the amniotic fluid was initially clear at the beginning of labour before becoming meconium stained. Most (63.8%) of the MSAF were detected during the active phase of labour. Nuchal cord and cord knots were respectively found in 21 (9.9%) and 20 (9.39%) cases of MSAF and CAF; the difference was not statistically significant (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s3_2"><title>3.2. Maternal Outcomes</title><p>There was a significantly higher risk of prolonged labour and caesarean delivery</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic characteristics of the study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  >Total N (%) [95% CI]</th><th align="center" valign="middle"  colspan="5"  >Sub-groups</th></tr></thead><tr><td align="center" valign="middle" >MSAF n(%)</td><td align="center" valign="middle" >CAF n(%)</td><td align="center" valign="middle"  colspan="3"  >P-value</td></tr><tr><td align="center" valign="middle" >Age (years):</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >33 (7.7) [5.5 - 10.8]</td><td align="center" valign="middle" >18 (8.45)</td><td align="center" valign="middle" >15 (7.04)</td><td align="center" valign="middle"  colspan="3"  >0.5862</td></tr><tr><td align="center" valign="middle" >[20 - 25[</td><td align="center" valign="middle" >79 (18.5) [15.0 - 22.6]</td><td align="center" valign="middle" >43 (20.19)</td><td align="center" valign="middle" >36 (16.90)</td><td align="center" valign="middle"  colspan="3"  >0.3824</td></tr><tr><td align="center" valign="middle" >[25 - 30]</td><td align="center" valign="middle" >191 (44.8) [40.1 - 49.7]</td><td align="center" valign="middle" >88 (41.31)</td><td align="center" valign="middle" >103 (48.36)</td><td align="center" valign="middle"  colspan="3"  >0.1435</td></tr><tr><td align="center" valign="middle" >&gt;30</td><td align="center" valign="middle" >123 (28.9) [24.7 ? 33.5]</td><td align="center" valign="middle" >64 (30.05)</td><td align="center" valign="middle" >59 (27.70)</td><td align="center" valign="middle"  colspan="3"  >0.5926</td></tr><tr><td align="center" valign="middle" >Marital status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >167 (39.2) [34.6 - 44]</td><td align="center" valign="middle" >88 (41.31)</td><td align="center" valign="middle" >79 (37.09)</td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Spinster</td><td align="center" valign="middle" >257 (60.3) [55.5 - 65.0]</td><td align="center" valign="middle" >125 (58.69)</td><td align="center" valign="middle" >132 (61.97)</td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Divorced</td><td align="center" valign="middle" >1 (0.2) [0.0 - 1.5]</td><td align="center" valign="middle" >0 (00)</td><td align="center" valign="middle" >1 (0.47)</td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Widow</td><td align="center" valign="middle" >1 (0.2) [0.0 - 1.5]</td><td align="center" valign="middle" >0 (00)</td><td align="center" valign="middle" >1 (0.47)</td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Level of Education</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="3"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >1 (0.2) [0.0 - 1.5]</td><td align="center" valign="middle" >0 (00)</td><td align="center" valign="middle"  colspan="2"  >1 (0.47)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >27 (6.3) [4.3 - 9.2]</td><td align="center" valign="middle" >15 (07.04)</td><td align="center" valign="middle"  colspan="2"  >12 (5.63)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >209 (49.1) [44.2 - 53.9]</td><td align="center" valign="middle" >110 (51.64)</td><td align="center" valign="middle"  colspan="2"  >99 (46.48)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >University</td><td align="center" valign="middle" >189 (44.4) [39.6 - 49.2]</td><td align="center" valign="middle" >88 (41.31)</td><td align="center" valign="middle"  colspan="2"  >101 (47.42)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Occupation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Housewife</td><td align="center" valign="middle" >93 (21.8) [18.1 - 26.1]</td><td align="center" valign="middle" >48 (22.54)</td><td align="center" valign="middle"  colspan="2"  >45 (21.13)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Trader</td><td align="center" valign="middle" >81 (19) [15.5 - 23.1]</td><td align="center" valign="middle" >45 (21.13)</td><td align="center" valign="middle"  colspan="2"  >36 (16.90)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Pupil/student</td><td align="center" valign="middle" >138 (32.4) [28.0 - 37.1]</td><td align="center" valign="middle" >70 (32.86)</td><td align="center" valign="middle"  colspan="2"  >68 (31.92)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Public employee</td><td align="center" valign="middle" >77 (18.1) [14.6 - 22.1]</td><td align="center" valign="middle" >32 (15.02)</td><td align="center" valign="middle"  colspan="2"  >45 (21.13)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Private employee</td><td align="center" valign="middle" >37 (8.7) [6.3 - 11.9]</td><td align="center" valign="middle" >18 (8.45)</td><td align="center" valign="middle"  colspan="2"  >19 (8.92)</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>MSAF = meconium stained amniotic fluid; CAF = clear amniotic fluid.</p><p>in cases of MSAF and especially when the stain was thick; 30.5% and 44.6% respectively (p &lt; 0.001). Common indications of caesarean delivery were cephalo-pelvic disproportion and acute fetal distress. Chorioamnionitis, instrumental delivery and puerperal sepsis were also higher in cases of MSAF although the differences were not statistically significant (P &gt; 0.05) (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s3_3"><title>3.3. Neonatal Outcomes</title><p>The meconium inhalation syndrome (MIS) was found in 5 (2.34%) cases of MSAF. The risks of low Apgar scores at the first and fifth minutes were multiplied by 8 times (RR = 8.16, p &lt; 0.001) and 3 times (RR = 3.42, P = 0.0023) respectively, in cases of MSAF. Fetal heart rate abnormalities, neonatal infection and neonatal asphyxia were significantly higher in cases with MSAF. All ten cases (4.7%) of perinatal deaths were in the group with MSAF (<xref ref-type="table" rid="table5">Table 5</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Obstetrical characteristics of the study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  >Total n(%) [95% CI]</th><th align="center" valign="middle"  colspan="3"  >Sub-groups</th></tr></thead><tr><td align="center" valign="middle" >MSAF n(%)</td><td align="center" valign="middle" >CAF n(%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Parity</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Primiparous</td><td align="center" valign="middle" >182 (45.1) [40.3 - 49.9]</td><td align="center" valign="middle" >96 (45.07)</td><td align="center" valign="middle" >96 (45.07)</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Multiparous</td><td align="center" valign="middle" >234 (54.9) [50.1 - 59.7]</td><td align="center" valign="middle" >117 (54.93)</td><td align="center" valign="middle" >117 (54.93)</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Number of ANC</td></tr><tr><td align="center" valign="middle" >&lt;4</td><td align="center" valign="middle" >71 (16.7) [13.3 - 20.6]</td><td align="center" valign="middle" >39 (18.31)</td><td align="center" valign="middle" >32 (15.02)</td><td align="center" valign="middle" >0.3623</td></tr><tr><td align="center" valign="middle" >≥4</td><td align="center" valign="middle" >355 (83.3) [79.4 - 86.7]</td><td align="center" valign="middle" >174 (81.69)</td><td align="center" valign="middle" >181 (84.98)</td><td align="center" valign="middle" >0.3623</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Gestational age at delivery (weeks)</td></tr><tr><td align="center" valign="middle" >[37 - 38]</td><td align="center" valign="middle" >60 (14.1) [11.0 - 17.8]</td><td align="center" valign="middle" >19 (8.92)</td><td align="center" valign="middle" >41 (19.25)</td><td align="center" valign="middle" >0.0022</td></tr><tr><td align="center" valign="middle" >]38 - 40]</td><td align="center" valign="middle" >220 (51.6) [46.8 - 56.5]</td><td align="center" valign="middle" >105 (49.30)</td><td align="center" valign="middle" >115 (53.99)</td><td align="center" valign="middle" >0.3328</td></tr><tr><td align="center" valign="middle" >]40 - 42]</td><td align="center" valign="middle" >146 (34.3) [29.8 - 39.0]</td><td align="center" valign="middle" >89 (41.78)</td><td align="center" valign="middle" >57 (26.76)</td><td align="center" valign="middle" >0.0011</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Pathologies in pregnancy</td></tr><tr><td align="center" valign="middle" >Anaemia</td><td align="center" valign="middle" >32 (21.6) [15.3 - 9.1]</td><td align="center" valign="middle" >14 (6.57)</td><td align="center" valign="middle" >18 (8.85)</td><td align="center" valign="middle" >0.4616</td></tr><tr><td align="center" valign="middle" >Malaria</td><td align="center" valign="middle" >70 (16.4) [13.1 - 0.4]</td><td align="center" valign="middle" >42 (19.72)</td><td align="center" valign="middle" >28 (13.15)</td><td align="center" valign="middle" >0.0673</td></tr><tr><td align="center" valign="middle" >HIV infection</td><td align="center" valign="middle" >13 (3.1) [1.7 - 5.3]</td><td align="center" valign="middle" >7 (3.29)</td><td align="center" valign="middle" >6 (2.82)</td><td align="center" valign="middle" >0.7781</td></tr><tr><td align="center" valign="middle" >Other STIs</td><td align="center" valign="middle" >32 (7.5) [5.3 - 10.5]</td><td align="center" valign="middle" >22 (10.33)</td><td align="center" valign="middle" >10 (4.69)</td><td align="center" valign="middle" >0.0272</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >27 (6.3) [4.3 - 9.2]</td><td align="center" valign="middle" >9 (4.23)</td><td align="center" valign="middle" >18 (8.45)</td><td align="center" valign="middle" >0.0739</td></tr><tr><td align="center" valign="middle" >History of C/S</td><td align="center" valign="middle" >49 (11.5) [8.7 - 15.0]</td><td align="center" valign="middle" >24 (11.27)</td><td align="center" valign="middle" >25 (11.74)</td><td align="center" valign="middle" >0.8792</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Mode of membrane rupture</td></tr><tr><td align="center" valign="middle" >Spontaneous</td><td align="center" valign="middle" >193 (45.3) [40.5 - 50.2]</td><td align="center" valign="middle" >105 (49.30)</td><td align="center" valign="middle" >88 (41.31)</td><td align="center" valign="middle" >0.0976</td></tr><tr><td align="center" valign="middle" >Artificial</td><td align="center" valign="middle" >233 (54.7) [49.8 - 59.5]</td><td align="center" valign="middle" >108 (50.70)</td><td align="center" valign="middle" >125 (58.69)</td><td align="center" valign="middle" >0.0976</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Delay of membrane rupture</td></tr><tr><td align="center" valign="middle" >Premature rupture</td><td align="center" valign="middle" >60 (14.1) [11.0 - 7.8]</td><td align="center" valign="middle" >28 (13.15)</td><td align="center" valign="middle" >32 (15.02)</td><td align="center" valign="middle" >0.5791</td></tr><tr><td align="center" valign="middle" >Prolonged rupture</td><td align="center" valign="middle" >58 (13.6) [10.6 - 7.3]</td><td align="center" valign="middle" >39 (18.31)</td><td align="center" valign="middle" >19 (8.92)</td><td align="center" valign="middle" >0.0047</td></tr></tbody></table></table-wrap><p>ANC = Antenatal care; C/S = Cesarean section; MSAF = meconium stained amniotic fluid; CAF = clear amniotic fluid; STIs = sexually transmitted infections.</p><table-wrap-group id="3"><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Characteristics of meconium stained amniotic fluid (MSAF)</title></caption><table-wrap id="3_1"><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Colour</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Green</td><td align="center" valign="middle" >111</td><td align="center" valign="middle" >52.1</td></tr><tr><td align="center" valign="middle" >Yellow</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >27.2</td></tr><tr><td align="center" valign="middle" >Pure meconium</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >20.7</td></tr><tr><td align="center" valign="middle" >Consistency</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Light</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >47.9</td></tr><tr><td align="center" valign="middle" >Thick</td><td align="center" valign="middle" >111</td><td align="center" valign="middle" >52.1</td></tr></tbody></table></table-wrap><table-wrap id="3_2"><table><tbody><thead><tr><th align="center" valign="middle" >Odour</th><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Fetid</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.2</td></tr><tr><td align="center" valign="middle" >Non fetid</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >94.8</td></tr><tr><td align="center" valign="middle" >Chronology</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >AF initially clear</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >23.5</td></tr><tr><td align="center" valign="middle" >AF stained at start</td><td align="center" valign="middle" >163</td><td align="center" valign="middle" >76.5</td></tr><tr><td align="center" valign="middle" >Moment of detection</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Before labour</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.9</td></tr><tr><td align="center" valign="middle" >Latent phase</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Active phase</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >63.8</td></tr><tr><td align="center" valign="middle" >Expulsion phase</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >4.2</td></tr><tr><td align="center" valign="middle" >Per operative</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >22.1</td></tr></tbody></table></table-wrap></table-wrap-group><p>AF = amniotic fluid.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Effect of MSAF on maternal morbidity</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >MSAF n (%)</th><th align="center" valign="middle" >CAF n (%)</th><th align="center" valign="middle" >RR [95% CI]</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Clinical chorioamniotitis</td><td align="center" valign="middle" >3 (1.4)</td><td align="center" valign="middle" >1 (0.5)</td><td align="center" valign="middle" >3 [0.50 - 17.95]</td><td align="center" valign="middle" >0.3120</td></tr><tr><td align="center" valign="middle" >Prolonged labour</td><td align="center" valign="middle" >65 (30.5)</td><td align="center" valign="middle" >19 (8.9)</td><td align="center" valign="middle" >3.42 [2.13 - 5.49]</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Instrumental delivery</td><td align="center" valign="middle" >6 (2.82)</td><td align="center" valign="middle" >1 (0.47)</td><td align="center" valign="middle" >6 [0.73 - 49.41]</td><td align="center" valign="middle" >0.1219</td></tr><tr><td align="center" valign="middle" >Caesarean delivery</td><td align="center" valign="middle" >95 (44.6)</td><td align="center" valign="middle" >48 (22.5)</td><td align="center" valign="middle" >1.97 [1.48 - 2.64]</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Puerperal infection</td><td align="center" valign="middle" >3 (1.4)</td><td align="center" valign="middle" >0 (00)</td><td align="center" valign="middle" >N?A</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>N-A: not applicable (The relative risk could not be calculated because all the cases were in the exposed group).</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Fetal and neonatal morbidity in cases of MSAF</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >MSAF(n = 213) n (%)</th><th align="center" valign="middle" >CAF (n = 213) n (%)</th><th align="center" valign="middle" >RR [95% CI]</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Fetal heart beat anomaly</td><td align="center" valign="middle" >71 (33.3)</td><td align="center" valign="middle" >29 (13.6)</td><td align="center" valign="middle" >2.90 [1.79 - 4.72]</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Apgar &lt; 7 at 1 minute</td><td align="center" valign="middle" >51 (23.9)</td><td align="center" valign="middle" >8 (3.8)</td><td align="center" valign="middle" >8.16 [3.81 - 17.47]</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Apgar &lt; 7 at 5 minutes</td><td align="center" valign="middle" >26 (12.2)</td><td align="center" valign="middle" >9 (4.2)</td><td align="center" valign="middle" >3.42 [1.73 - 6.76]</td><td align="center" valign="middle" >0.0023</td></tr><tr><td align="center" valign="middle" >Neonatal resuscitation</td><td align="center" valign="middle" >35 (16.4)</td><td align="center" valign="middle" >15 (7.0)</td><td align="center" valign="middle" >2.66 [1.59 - 4.46]</td><td align="center" valign="middle" >0.0026</td></tr><tr><td align="center" valign="middle" >NNI</td><td align="center" valign="middle" >28 (13.1)</td><td align="center" valign="middle" >5 (2.3)</td><td align="center" valign="middle" >5.6 [2.46 - 12.71]</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >NNA</td><td align="center" valign="middle" >19 (8.9)</td><td align="center" valign="middle" >7 (3.3)</td><td align="center" valign="middle" >2.71 [1.38 - 5.33]</td><td align="center" valign="middle" >0.0186</td></tr><tr><td align="center" valign="middle" >Admission in neonatology</td><td align="center" valign="middle" >42 (19.7)</td><td align="center" valign="middle" >13 (6.1)</td><td align="center" valign="middle" >3.41 [2.03 - 5.73]</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Deaths</td><td align="center" valign="middle" >10 (4.7)</td><td align="center" valign="middle" >0 (00)</td><td align="center" valign="middle" >N/A</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>N-A: not applicable (The relative risk could not be calculated because all the cases were in the exposed group); NNI: Neonatal infection, NNA: Neonatal asphyxia.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The aim of this study was to determine the maternal and fetal outcomes in case of meconium stained amniotic fluid observed during labour of term singleton pregnancy in cephalic presentation. We found that the prevalence of MSAF was 11.15%. MSAF was associated with a significant risk of caesarean delivery and prolonged labor. Also, MSAF was associated with the following fetal and neonatal complications; fetal heart rate abnormalities, low Apgar score at the 5<sup>th</sup> minute, need for neonatal resuscitation, neonatal asphyxia and neonatal infection. Meconium aspiration syndrome (MAS) was found in 2.34% of MSAF cases. Perinatal mortality was 2.34% and all cases of death occurred in the thick MSAF group.</p><p>We found a prevalence of MSAF of 11.15%. This finding is within the 5% to 24.6% interval stated in the literature [<xref ref-type="bibr" rid="scirp.86477-ref6">6</xref>] , although higher than the 8.3% reported by Patil K.et al. in 2006 in India [<xref ref-type="bibr" rid="scirp.86477-ref18">18</xref>]. The higher prevalence observed in the current study could be explained by the fact that the study was conducted in two tertiary level hospitals in the capital city that receive referrals from the peripheral health facilities. Thick MSAF represented 52.1% and light MSAF represented 47.9%. This concurs with findings from other low-and-middle income countries; 53% in Guinea [<xref ref-type="bibr" rid="scirp.86477-ref24">24</xref>] and 64.3% in India [<xref ref-type="bibr" rid="scirp.86477-ref18">18</xref>]. The high frequency of thick MSAF could be due to the fact that evaluating amniotic fluid as lightly stained is very subjective and as such, the prevalence may greatly vary from one author to the other [<xref ref-type="bibr" rid="scirp.86477-ref9">9</xref>].</p><p>The mean gestational age was greater in the group with MSAF compared to the CAF group (39.7 vs 39.2 weeks: p = 0.0001). Moreover, the incidence of MSAF was 60.9% in cases with gestational age greater than 40 weeks. This positive correlation between advanced gestational age and the prevalence of MSAF concurs with previous observations made by Meis et al. [<xref ref-type="bibr" rid="scirp.86477-ref7">7</xref>] and Millar et al. [<xref ref-type="bibr" rid="scirp.86477-ref8">8</xref>] who found that the prevalence of MSAF could be up to 50% at 42 weeks of gestation.</p><p>Similar to studies done by by Erum et al. [<xref ref-type="bibr" rid="scirp.86477-ref11">11</xref>] and Salma et al. [<xref ref-type="bibr" rid="scirp.86477-ref12">12</xref>] , we found MSAF to be associated with some maternal morbidities; a two-fold increase in caesarean delivery and a three-fold increase in chorioamnionitis and prolonged labour. We may attribute the high incidence of caesarean deliveries in this study to inadequate intrapartum fetal heart monitoring. As such, the presence of meconium in the amniotic fluid was an alarming sign of fetal distress and treated accordingly by emergency caesarean section.</p><p>After stratifying maternal morbidities according to the consistency of the MSAF, it was noted that thick MSAF compared to light MSAF and clear amniotic fluid (CAF) respectively increased the risk of caesarean delivery by 1.67 and 2.48. Similar results were found by Aparna et al. [<xref ref-type="bibr" rid="scirp.86477-ref9">9</xref>] and Nirmala et al. [<xref ref-type="bibr" rid="scirp.86477-ref13">13</xref>] in India where the risk of caesarean delivery was multiplied by 3 in case of thick MSAF. Likewise, all the cases of puerperal infections were found in the group with thick MSAF. Thick MSAF increased maternal morbidities significantly in cases of MSAF.</p><p>Fetal morbidities were significantly higher in case of MSAF. These included non-reassuring fetal heart rhythm (p &lt; 10<sup>−4</sup>), low Apgar scores at first and fifth minutes (p &lt; 10<sup>−4</sup> and p &lt; 10<sup>−2</sup> respectively), neonatal infection (NNI) and neonatal asphyxia (NNA) (p &lt; 10<sup>−3</sup> and p &lt; 10<sup>−1</sup> respectively). Similar results were obtained in India [<xref ref-type="bibr" rid="scirp.86477-ref9">9</xref>] and Guinea [<xref ref-type="bibr" rid="scirp.86477-ref25">25</xref>] where fetal heart rhythm anomaly was 5 times higher in case of MSAF. The various proportions of low Apgar scores (&lt;7) at the first minute were 3.8%, 23.9% and 36.9% in case of CAF, MSAF and thick MSAF respectively. In a similar order, low Apgar scores at the fifth minute were respectively 4.2%, 12.2% and 20.7% in case of CAF, MSAF and thick MSAF respectively. These differences in proportions were significantly higher in the group with thick MSAF both at the first and fifth minutes {1<sup>st</sup> minute (RR = 9.83; p &lt; 10<sup>−4</sup>) and 5<sup>th</sup> minute (RR = 4.90; p &lt; 10<sup>−2</sup>)}. Patil et al. obtained similar results with low Apgar scores in 19% of cases of MSAF [<xref ref-type="bibr" rid="scirp.86477-ref18">18</xref>]. Nirmala et al. [<xref ref-type="bibr" rid="scirp.86477-ref13">13</xref>] found low Apgar scores in 16% of cases with MSAF and only in the first minute. The persistent difference in Apgar scores both at 1<sup>st</sup> and 5<sup>th</sup> minutes and in case of CAF observed in our series could suggest insufficient neonatal resuscitation. There was an overall drop in the proportions of low Apgar scores from the 1st to the 5<sup>th</sup> minute. NNI (RR = 5.6; p = 10<sup>−4</sup>) and NNA (RR = 2.71; p &lt; 10<sup>−1</sup>) were significantly more common in cases with MSAF. Noteworthy, the relative risk values are higher for thick MSAF compared to CAF; RR = 6.61 for NNI and RR = 4.39 for NNA. The observed value in the current study is higher than those recently obtained by Kumari et al. [<xref ref-type="bibr" rid="scirp.86477-ref26">26</xref>] and by Rajlaxmi et al. [<xref ref-type="bibr" rid="scirp.86477-ref27">27</xref>]. This high association of NNI and MSAF in our series could be explained by high proportions of prolonged premature rupture of membranes and resuscitation technics in the group with MSAF (p = 0.0047 and p = 0.0026 respectively). Lastly, perinatal mortality was 4.69% in the group with MSAF versus 0% in the group with CAF; and all the cases were thick MSAF. Similar rates were obtained by Salma et al. [<xref ref-type="bibr" rid="scirp.86477-ref12">12</xref>] with risk of death multiplied by 2 in case of MSAF. Patil et al. [<xref ref-type="bibr" rid="scirp.86477-ref18">18</xref>] noted a mortality of 4%, all in the group with thick MSAF.</p><p>Our results should be interpreted within the study’s limitations. These include the sole use of fetal heart rhythm to diagnose acute fetal distress and the short term postpartum follow up period of 72 hours (coinciding with the hospital discharge of participants). As such, some complications could be missed because of this early exit from the hospital. However, based on well followed-up patients, we have used a cohort design to provide a contribution of level II scientific evidence to the scarcity on the outcomes of maternal and fetal outcomes in case of meconium stained amniotic fluid observed during labour of term singleton pregnancy in the sub-Saharan African region. These findings may guide obstetricians and midwives in making informed clinical decisions in their therapeutic strategies MSAF observed during labour in these resource-constrained environments.</p></sec><sec id="s5"><title>5. Conclusion</title><p>MSAF observed during labour of term singleton pregnancies in cephalic presentations was associated with maternal and fetal complications. Its detection during labor warrants rigorous intra partum and postpartum monitoring for a timely diagnosis and management of these complications.</p></sec><sec id="s6"><title>Declaration of Interest</title><p>The authors report no declaration of interest.</p></sec><sec id="s7"><title>Funding</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></sec><sec id="s8"><title>Cite this paper</title><p>Dohbit, J.S., Mah, E.M., Essiben, F., Nzene, E.M., Meka, E.U.N., Foumane, P., Tochie, J.N., Kadia, B.M., Elong, F.A. and Nana, P.N. (2018) Maternal and Fetal Outcomes Following Labour at Term in Singleton Pregnancies with Meconium-Stained Amniotic Fluid: A Prospective Cohort Study. Open Journal of Obstetrics and Gynecology, 8, 790-802. https://doi.org/10.4236/ojog.2018.89082</p></sec><sec id="s9"><title>Appendix 1. Questionnaire</title><p>Patient identification:</p><p>File N˚: _________ Date: ____ /____/____</p><p>Contact adresss: ___________________ Age (years): _______</p><p>Marital Status: maried □; single □; divorced ,; widow ,</p><p>Level of education: not formal,; primary ,; secondary ,; higher ,</p><p>Occupation: housewife , student , civil servant , private worker , independant ,</p><p>Monthly revenu (Fcfa):</p><p>&lt;25,000 , [25,000 - 50,000[ , [50,000 - 100,000[ , ≥ 100,000 ,</p><p>Last mentrual period:__/__/__ Expected day of confinment: _/_/_ Gestational age (weeks-days) ____________________</p><p>Presenting complaint: labour pains □; vaginal bleeding,; lost of liquoir□; others____________________</p><p>History of pregnancy:</p><p>No of antenatal care visits: ___; VIH serology: negative , positive ,</p><p>Level of haemoglobin: &lt;10 g/dl ,; ≥ 10g/dl ,</p><p>Pathologies in pregnanacy: anaemia□; malaria □; urinary infection ,; diabetes ,; Hypertension , others ___________________________________</p><p>Gravida ___ Para__________________; No of past cesarean sections: ____</p><p>Medical History: None □; Hypertension: Yes ,/No ,; diabetes: Yes ,/No ,</p><p>Cardiopathy: Yes □/No □ others ____________________</p><p>Monitoring of labour (partograph)</p><p>Mode of rupture of membranes: Spontanous , Artificial ,</p><p>Delay of rupture of membranes: Premature Rupture: Yes ,/No ,</p><p>Prolonged Rupture: Yes ,/No ,</p><p>Nature of liquoir: Clear ,/Meconial , If meconial, colour: green ,; yellow ,; purulent ,</p><p>Consistency of liquoir: light , thick ,; Odour of liquoir: foul smelling , not foul smelling ,</p><p>Moment of detection of MSAF: before onset of labour ,; latent phase ,; active phase ,; expulsion phase ,; intra operative ,</p><p>MSAF noticed immediately at membrane rupture ,/Initial clear liquoir followed by MSAF ,</p><p>Fetal heart rate anomaly during labour: Yes ,/No ,</p><p>If Yes: Tachycardia , Bradycardia , Deceleration ,</p><p>If deceleration: type I , type II , type III ,</p><p>Maternal fever (temp &gt; 37.8): Yes ,/No ,; Maternal tachycardia (&gt;100): Yes ,/No ,</p><p>Uterine pain on palpation: Yes ,/No , Clinical chorioamnionitis: Yes ,/No ,</p><p>Mode of delivery:</p><p>Normal vaginal delivery □;</p><p>Instrumental □ (Indication: fetal distress , cephalopelvic disproportion ,; fatigue , others___________)</p><p>Cesaerian section □ (Indication: fetal distress □; cephalopelvic disproportion □; others ____________________________)</p><p>Duration of labour: Normal , Prolonged ,</p><p>If prolonged: 1<sup>st</sup> stage , duration____ 2<sup>nd</sup> stage , duration____ 3<sup>rd</sup> stage , duration____</p><p>Placenta: weight(g) __________; meconial stained: Yes □ /No □</p><p>Calcifications: Yes ,/No ,; other anomalies________________________</p><p>Umbilical Cord: meconial stained: Yes □ /No □; cord knot: Yes □ /No □</p><p>Cord round neck: Yes ,/No ,; cord prolapse: Yes ,/No , other anomalies _________________________</p><p>State of newborn:</p><p>Gender: Male , Female ,; Weight(g) _______________</p><p>APGAR: 1<sup>st</sup> min____/10; 5<sup>th</sup> min____/10</p><p>Resuscitation: Yes ,/No ,; if yes: Duration____________________ min, Method_________________</p><p>Respiratory distress: Yes ,/No ,; Neonatal Asphyxia: Yes ,/No ,</p><p>Meconium inhalation syndrome: Yes □,/No ,; Neonatal Infection: Yes ,/No,</p><p>Neonatal unit admission: Yes ,/No ,;</p><p>Neonatal death: Yes ,/No ,</p><p>Follow-up of the mother and newborn</p><p>NNI: Neonatal infection, NNA: Neonatal asphyxia, RD: Respiratory distress, MIS: Meconium inhalation syndrome.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.86477-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Université Médicale Virtuelle Francophone (2011) Physiologie du liquide amniotique. Université médicale virtuelle francophone.</mixed-citation></ref><ref id="scirp.86477-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Xavier, C., Pascal, V., Denis, T., Issam, B. and Francis, P. (2009) Physiologie du liquide amniotique. Dans: Tsunami, éditeur. Le manuel du résident obstétrique. Paris: Encyclopédie médico-chirurgicale, 99-119.</mixed-citation></ref><ref id="scirp.86477-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Lopez, R.Y.C. and Martinez, R.D. (2002) In utéro defecation. Ultrasound in Obstetrics &amp; Gynecology, 19, 531.</mixed-citation></ref><ref id="scirp.86477-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Collège National des Gynécologues et Obstétriciens Francais. (2005) Extraits des mises à jour en gynécologie et obstétrique tome XXIX. Collège National des Gynécologues et Obstétriciens Francais, Paris.</mixed-citation></ref><ref id="scirp.86477-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Laxmi, N.I. (2010) Perinatal Outcome in Meconiun Stained Amniotic Fluid [Dissertation]. Rajiv Gandhi University of Health Sciences, Bangalore, 120 p.</mixed-citation></ref><ref id="scirp.86477-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Cleary, G.M. and Wiswell, T.E. (1998) Meconiun Stained Amniotic Fluid and Meconiun Aspiration Syndrome, an Update. Pediatric Clinics of North America, 45, 511-529. https://doi.org/10.1016/S0031-3955(05)70025-0</mixed-citation></ref><ref id="scirp.86477-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Meis, P.J., Hall, M., Marshak, J.R. and Hobel, C.J. (1978) Obstetrics &amp; Gynecology, 131, 509-513.</mixed-citation></ref><ref id="scirp.86477-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Millar, F.C. and Read, J.A. (1981) Intrapartum Assessment of the Postdate Fetus. American Journal of Obstetrics and Gynecology, 141, 516-520.  
https://doi.org/10.1016/S0002-9378(15)33271-3</mixed-citation></ref><ref id="scirp.86477-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Aparna, C., Miltra, P., Seth, S., Das, A., Subhadeep, B. and Joydip, P. (2013) Study on Risk Factors of Meconium Stained Amniotic Fluid and Comparison of Pregnancy Outcome in Clear and Meconium Stained Amniotic Fluid in a Tertiary Hospital, Kolkata India. International Journal of Biological and Medical Research, 4, 3084-3087.</mixed-citation></ref><ref id="scirp.86477-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Dohbit, J.S., Foumane, P., Tochie, J.N., Mamoudou, F., Temgoua, M.N., Tankeu, R., Aletum, V. and Mboudou, E. (2017) Maternal and Neonatal Outcomes of Vaginal Breech Delivery for Singleton Term Pregnancies in a Carefully Selected Cameroonian Population: A Cohort Study. BMJ Open, 7, e017198.  
https://doi.org/10.1136/bmjopen-2017-017198</mixed-citation></ref><ref id="scirp.86477-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Erum, M.S., Sadaf, M. and Majid, A.S. (2010) Neonatal Outcome in Meconium Stained Amniotic Fluid-One Year Experience. Journal of Pakistan Medical Association, 60, 711-714.</mixed-citation></ref><ref id="scirp.86477-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Salma, B.N. and Summiya, M. (2011) Association of Meconium Stained Amniotic Fluid with Perinatal Outcome in Pregnant Women of 37-42 Weeks Gestation. Pakistan Journal Of Surgery, 27, 292-298.</mixed-citation></ref><ref id="scirp.86477-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nirmala</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> Anshu</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> Urmila</surname><given-names> D. and Ayali </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>Meconium Staining of Amniotic Fluid, a Poor Indicator of Fetal Compromise</article-title><source> JK Science</source><volume> 12</volume>,<fpage> 184</fpage>-<lpage>186</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.86477-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">University Hospitals of Morecambe Bay (2010) Meconium Liquor Management of Labour and Neonate. University Hospitals of Morecambe Bay, Morecambe Bay.</mixed-citation></ref><ref id="scirp.86477-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mid Essex Hospital Services (2010) Guideline for the Management of Meconium Stained Liquor. Mid Essex Hospital Services.</mixed-citation></ref><ref id="scirp.86477-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Intensive Care Nursery. House Staff Manual (2004) Management of Infants Born through Meconiun Stained Amniotic Fluid. UCSF Children’s Hospital, University of California, Oakland.</mixed-citation></ref><ref id="scirp.86477-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Rathor, A.M., Singh, R. and Ramji, S. (2002) Randomized Trial of Amnioinfusion during Labour with Meconiun Stained Amniotic Fluid. BJOG, 109, 17-20.  
https://doi.org/10.1111/j.1471-0528.2002.01140.x</mixed-citation></ref><ref id="scirp.86477-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Patil, K.P., Suargy, M.K. and Samatha, K. (2006) A One Year Cross Sectional Study of Management Practices of Meconium Stained Amniotic Fluid and Perinatal Outcome. The Journal of Obstetrics and Gynecology of India, 56, 128-130.</mixed-citation></ref><ref id="scirp.86477-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Yoder, B.A., Kirsch, E.A., Barth, W.H. and Gordon, M.C. (2002) Changing Obstetric Practices Associated with Decreasing Incidence of Meconium Aspiration Syndrome. Obstetrics &amp; Gynecology, 99, 731-739.  
https://doi.org/10.1097/00006250-200205000-00011</mixed-citation></ref><ref id="scirp.86477-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Lwanga, S.K., Lemeshow, S. and Organization, W.H. (1991) Sample Size Determination in Health Studies: A Practical Manual.  
http://www.who.int/iris/handle/10665/40062</mixed-citation></ref><ref id="scirp.86477-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Committee on Obstetric Practice, American College of Obstetricians and Gynecologists (2005) ACOG Committee Opinion. Number 326, December 2005. Inappropriate Use of the Terms Fetal Distress and Birth Asphyxia. Obstetrics &amp; Gynecology, 106, 1469-1470. https://doi.org/10.1097/00006250-200512000-00056</mixed-citation></ref><ref id="scirp.86477-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Sarnat, H.B. and Sarnat, M.S. (1976) Neonatal Encephalopathy Following Fetal Distress. A Clinical and Electroencephalographic Study. Archives of Neurology, 33, 696-705. https://doi.org/10.1001/archneur.1976.00500100030012</mixed-citation></ref><ref id="scirp.86477-ref23"><label>23</label><mixed-citation publication-type="book" xlink:type="simple">American Academy of Pediatrics and American College of Obstetricains and Gynecologists (2002) Care of the Neonate. In: Gilstrap, L.C. and Oh, W., Eds., Guidelines for Perinatal Care, 5th Edition, American Academy of Pediatrics, Elk Grove Village, 196-197.</mixed-citation></ref><ref id="scirp.86477-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Cecil, A.K., Apeawusu, B.A., Kariwiga, G. and Onenama, R. (1996) A Case-Control Study of Meconium Staining of Amniotic Fluid in Labour at Port Moresby General Hoapital to Determine Associated Risk Factors and Perinatal Outcome. PNG Medical Journal, 39, 297-309.</mixed-citation></ref><ref id="scirp.86477-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Wiswell, T.E., Knight, G.R. and Finer, N.N. (2002) A Multicenter, Randomized, Controlled Trial Comparing Surfaxin (Lucinactant) Lavage with Standard Care for Treatment of Meconium Aspiration Syndrome. Pediatrics, 109, 1081-1087.  
https://doi.org/10.1542/peds.109.6.1081</mixed-citation></ref><ref id="scirp.86477-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Kumari, S., Gupta, S.N., Mahato, I.P., Giri, R., Yadav, A., Thakur, A., et al. (2012) Maternal and Fetal Outcome in Term Labour with Meconium Stained Amniotic Fluid. Health Renaissance, 10, 198-202. https://doi.org/10.3126/hren.v10i3.7135</mixed-citation></ref><ref id="scirp.86477-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Rajlaxmi, M. and Manika, A. (2013) Fetal Outcome in Meconium Stained Deliveries. Journal of Clinical and Diagnostic Research, 7, 2874-2876.</mixed-citation></ref></ref-list></back></article>